1. Epidemiology and Global Health
  2. Plant Biology
Download icon

Plant Pathology: Plasmid-powered evolutionary transitions

  1. Ryan A Melnyk
  2. Cara H Haney  Is a corresponding author
  1. University of British Columbia, Canada
Insight
  • Cited 1
  • Views 1,292
  • Annotations
Cite this article as: eLife 2017;6:e33383 doi: 10.7554/eLife.33383

Abstract

The acquisition of a virulence plasmid is sufficient to turn a beneficial strain of Rhodococcus bacteria into a pathogen.

Main text

Many bacteria are closely associated with eukaryotic hosts. This relationship can be mutually beneficial, commensal (that is, it benefits one party without affecting the other), or pathogenic. Moreover, and perhaps surprisingly, there are many examples of pathogenic bacteria that are close relatives of mutualistic or commensal bacteria (Wood et al., 2001). For example, while most strains of E. coli are commensal, pathogenic strains – such as those that cause food poisoning – emerged from commensal ancestors (Pupo et al., 2000).

Historically, the bacterial genus Rhodococcus has been synonymous with pathogenesis because most described strains could cause a plant disease called leafy gall and stunt the growth of their plant hosts (Stes et al., 2011). Recently, it was found that some Rhodococcus strains are benign, and some are constituents of a healthy microbiome in plants (Bai et al., 2015; Hong et al., 2016). Now, in eLife, Jeff Chang of Oregon State University and co-workers – including Elizabeth Savory, Skylar Fuller and Alexandra Weisberg as joint first authors – report using a collection of Rhodococcus strains to study the molecular mechanisms that underlie distinct bacterial lifestyles (Savory et al., 2017).

Savory et al. isolated 60 strains of Rhodococcus bacteria from healthy and diseased plants from 16 nurseries over a period of several years and then sequenced their genomes and plasmids (which usually contain the virulence genes which make Rhodococcus pathogenic). The researchers compared pathogenic and commensal strains and used single nucleotide polymorphisms to reconstruct evolutionary histories within the Rhodococcus genus. They found relatively little correlation between the genome sequences of a strain and the DNA sequences in the plasmids. In particular, they found that isolates with similar genomes could have plasmids with radically different virulence genes, while plasmids with similar virulence genes could be found in strains with very different genomes. This suggests that the emergence of pathogenic strains may be driven by the transfer of plasmids between strains that are relatively evolutionarily distant from each other.

The researchers identified Rhodococcus isolates that lack a virulence plasmid but are close relatives of isolates that possess a plasmid. They showed that Rhodococccus isolates that lack a virulence plasmid can colonize Nicotiana benthamiana, a model plant that is susceptible to Rhodococcus infection. However, rather than causing disease, the strains lacking a virulence plasmid promoted the development of lateral roots and root hairs (Figure 1). This indicates that beneficial and pathogenic Rhodococcus are closely related, which led Savory et al. to hypothesize that the commensal and pathogenic Rhodococcus may evolve by the acquisition or loss of a virulence plasmid.

The good and bad sides of Rhodococcus.

The acquisition of a virulence plasmid (yellow) can transform benign commensal strains of Rhodococcus (blue) into pathogenic strains (blue and yellow) that stunt the growth of the plant and its roots (left) compared with a healthy plant (right). However, this process is reversible, and the loss of the virulence plasmid results in the bacteria becoming commensal again.

Savory et al. went on to experimentally demonstrate that pathogenic Rhodococcus strains can evolve from commensals. They showed that the introduction of a virulence plasmid from a pathogenic isolate into a beneficial strain was sufficient to cause disease in N. benthamiana. They also showed that the transition from commensal to pathogen is reversible: plasmid loss causes a virulent strain to become beneficial. By combining experimental data with genomic evidence, Savory et al. conclusively demonstrate that a readily transmissible plasmid is necessary and sufficient to reversibly transform beneficial Rhodococcus strains into pathogens.

Recently, it has been alleged that various strains of Rhodococcus are the cause of “pistachio bushy top syndrome” (PBTS), which has affected millions of pistachio trees in the United States and resulted in substantial economic losses (Stamler et al., 2015). However, rapid evolutionary changes present a challenge in identifying the pathogenic agents responsible for PBTS. Savory et al. tested the virulence of two Rhodococcus strains purported to be the causative agents of PBTS on several different hosts: they found that both isolates were not pathogenic. Moreover, they report that they were unable to amplify Rhodococcus virulence genes by PCR. This, combined with the fact that the published genomes of these strains do not contain virulence loci (Stamler et al., 2016), suggests that the plasmid was lost during isolation or that the disease was misdiagnosed.

The ambiguity of the cause of PBTS underscores the need for multiple independent methods that can verify the identity of an emerging plant pathogen, particularly when it has benign close relatives. To this end, Savory et al. developed an alternative method of identifying virulent strains of Rhodococcus based on recombinase polymerase amplification, and showed that this test could robustly discriminate between pathogenic and beneficial strains by targeting conserved loci in the virulence plasmid.

The work of Savory et al. provides insights into the evolutionary history of plant pathogens and mutualists. In particular, the coincidence of virulence and mutualism within the Rhodococcus clade suggests that both strategies are adaptive under certain conditions: sustained positive selection for one lifestyle would be unlikely to result in closely related strains with dramatically different effects on plant health. Building on this work may illuminate the evolutionary mechanisms that drive transitions from beneficial to pathogenic lifestyles in bacteria. This in turn could have profound implications for the management of emerging agricultural diseases and the evolution of plant-microbe interactions.

References

Article and author information

Author details

  1. Ryan A Melnyk

    Ryan A Melnyk is in the Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6331-2210
  2. Cara H Haney

    Cara H Haney is in the Department of Microbiology and Immunology and the Michael Smith Laboratories, University of British Columbia, Vancouver, Canada.

    For correspondence
    cara.haney@msl.ubc.ca
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6099-6677

Publication history

  1. Version of Record published: December 12, 2017 (version 1)

Copyright

© 2017, Melnyk et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,292
    Page views
  • 154
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Computational and Systems Biology
    2. Epidemiology and Global Health
    Ewan Colman et al.
    Research Article

    Humans and other group-living animals tend to distribute their social effort disproportionately. Individuals predominantly interact with a small number of close companions while maintaining weaker social bonds with less familiar group members. By incorporating this behavior into a mathematical model, we find that a single parameter, which we refer to as social fluidity, controls the rate of social mixing within the group. Large values of social fluidity correspond to gregarious behavior, whereas small values signify the existence of persistent bonds between individuals. We compare the social fluidity of 13 species by applying the model to empirical human and animal social interaction data. To investigate how social behavior influences the likelihood of an epidemic outbreak, we derive an analytical expression of the relationship between social fluidity and the basic reproductive number of an infectious disease. For species that form more stable social bonds, the model describes frequency-dependent transmission that is sensitive to changes in social fluidity. As social fluidity increases, animal-disease systems become increasingly density-dependent. Finally, we demonstrate that social fluidity is a stronger predictor of disease outcomes than both group size and connectivity, and it provides an integrated framework for both density-dependent and frequency-dependent transmission.

    1. Epidemiology and Global Health
    Daniel J Laydon et al.
    Research Article Updated

    Background:

    Sanofi-Pasteur’s CYD-TDV is the only licensed dengue vaccine. Two phase three trials showed higher efficacy in seropositive than seronegative recipients. Hospital follow-up revealed increased hospitalisation in 2–5- year-old vaccinees, where serostatus and age effects were unresolved.

    Methods:

    We fit a survival model to individual-level data from both trials, including year 1 of hospital follow-up. We determine efficacy by age, serostatus, serotype and severity, and examine efficacy duration and vaccine action mechanism.

    Results:

    Our modelling indicates that vaccine-induced immunity is long-lived in seropositive recipients, and therefore that vaccinating seropositives gives higher protection than two natural infections. Long-term increased hospitalisation risk outweighs short-lived immunity in seronegatives. Independently of serostatus, transient immunity increases with age, and is highest against serotype 4. Benefit is higher in seropositives, and risk enhancement is greater in seronegatives, against hospitalised disease than against febrile disease.

    Conclusions:

    Our results support vaccinating seropositives only. Rapid diagnostic tests would enable viable ‘screen-then-vaccinate’ programs. Since CYD-TDV acts as a silent infection, long-term safety of other vaccine candidates must be closely monitored.

    Funding:

    Bill & Melinda Gates Foundation, National Institute for Health Research, UK Medical Research Council, Wellcome Trust, Royal Society.

    Clinical trial number:

    NCT01373281 and NCT01374516.